Mechanical Pre-Conditioning With Acute Circulatory Support Before Reperfusion Limits Infarct Size in Acute Myocardial Infarction

JACC: Heart Failure

Volumn 3, Issue 11, 2015, Pages 873-882

  Kapur, Navin K ^a   Qiao, Xiaoying ^a   Paruchuri, Vikram ^a   Morine, Kevin J ^a   Syed, Wajih ^a   Dow, Sam ^a   Shah, Nimish ^a   Pandian, Natesa ^a   Karas, Richard H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

myocardial infarction; reperfusion injury; ventricular assist devices

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA; BIOLOGICAL MARKER; GLYCOGEN SYNTHASE KINASE 3; PHOSPHOTRANSFERASE; STROMAL CELL DERIVED FACTOR 1;

ACUTE HEART INFARCTION; ADULT; ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; ASSISTED CIRCULATION; CONTROLLED STUDY; CORONARY REPERFUSION; CORRELATIONAL STUDY; ENZYME ACTIVITY; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; REPERFUSION; SIGNAL TRANSDUCTION; WALL STRESS; ANIMAL; COMPARATIVE STUDY; DEVICES; DISEASE MODEL; HEART MUSCLE REPERFUSION; HEMODYNAMICS; MECHANICAL STRESS; METABOLISM; MORTALITY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PIG; PROCEDURES;

ANIMALS; BIOMARKERS; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PHOSPHOTRANSFERASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; STRESS, MECHANICAL; SUS SCROFA;

EID: 84984827910     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.06.010     Document Type: Article

References (23)

1. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 125 (2012), 188–197.
2. Menees, D.S., Peterson, E.D., Wang, Y., et al. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 369 (2013), 901–909.
3. Hausenloy, D.J., Yellon, D.M., Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123 (2013), 92–100.
4. Kapur, N.K., Paruchuri, V., Urbano-Morales, J.A., et al. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation 128 (2013), 328–336.
5. Yang, X., Cohen, M.V., Downey, J.M., Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther 24 (2010), 225–234.
6. Hu, X., Dai, S., Wu, W.J., Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116 (2007), 654–663.
7. Haider, HKh, Jiang, S., Idris, N.M., Ashraf, M., IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103 (2008), 1300–1308.
8. Acharya, D., Loyaga-Rendon, R.Y., Tallaj, J.A., Pamboukian, S.V., Sasse, M.F., Circulatory support for shock complicating myocardial infarction. J Invasive Cardiol 26 (2014), E109–E114.
9. Baan, J., van der Velde, E.T., de Bruin, H.G., et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70 (1984), 812–823.
10. Kass, D.A., Yamazaki, T., Burkhoff, D., Maughan, W.L., Sagawa, K., Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 73 (1986), 586–595.
11. Quinones, M.A., Mokotoff, D.M., Nouri, S., Winters, W.L. Jr., Miller, R.R., Noninvasive quantification of left ventricular wall stress. Validation of method and application to assessment of chronic pressure overload. Am J Cardiol 45 (1980), 782–790.
12. Schairer, J.R., Keteyian, S., Henry, J.W., Stein, P.D., Left ventricular wall tension and stress during exercise in athletes and sedentary men. Am J Cardiol 71 (1993), 1095–1098.
13. Reichek, N., Devereux, R.B., Reliable estimation of peak left ventricular systolic pressure by M-mode echocardiographic determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. Am Heart J, 103, 1982, 202.
14. Kapur, N.K., Deming, C.B., Kapur, S., et al. Hemodynamic modulation of endocardial thromboresistance. Circulation 115 (2007), 67–75.
15. Heidenreich, P.A., Albert, N.M., Allen, L.A., et al., American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6 (2013), 606–619.
16. Ezekowitz, J.A., Kaul, P., Bakal, J.A., Armstrong, P.W., Welsh, R.C., McAlister, F.A., Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol 53 (2009), 13–20.
17. Ezekowitz, J.A., Armstrong, P.W., Granger, C.B., et al. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: an Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) substudy. Am Heart J 160 (2010), 272–278.
18. Meyns, B., Stolinski, J., Leunens, V., Verbeken, E., Flameng, W., Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 41 (2003), 1087–1095.
19. Shiiya, N., Zelinsky, R., Deleuze, P.H., Loisance, D.Y., Changes in hemodynamics and coronary blood flow during left ventricular assistance with the Hemopump. Ann Thorac Surg 53 (1992), 1074–1079.
20. O'Neill, W.W., Schreiber, T., Wohns, D.H., et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 27 (2014), 1–11.
21. Hausenloy, D.J., Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). Curr Pharm Des 19 (2013), 4544–4563.
22. Miura, T., Tanno, M., Sato, T., Mitochondrial kinase signalling pathways in Myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc Res 88 (2010), 7–15.
23. Juhaszova, M., Zorov, D.B., Yaniv, Y., Nuss, H.B., Wang, S., Sollott, S.J., Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 104 (2009), 1240–1252.